| RS184812963 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS184814386 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS184815126 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1848167319 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aplastic anemia, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1848169364 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1848171715 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis, Familial hemophagocytic lymphohistiocytosis |
| RS1848174771 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, PRF1-related disorder |
| RS1848176232 |
DENND5A
|
Health Risk |
Pathogenic |
— |
| RS1848183403 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1848204643 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS184820566 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1848214400 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1848218666 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1848219856 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis, Familial hemophagocytic lymphohistiocytosis |
| RS1848222357 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis |
| RS184825524 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS184828562 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS184829061 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1848291332 |
FAR1
|
Health Risk |
Pathogenic |
— |
| RS184830847 |
DICER1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS1848315820 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS1848316236 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1848316496 |
FAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 1, FAS-related disorder |
| RS1848319199 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jervell and Lange-Nielsen syndrome 1, Long QT syndrome 1 |
| RS1848319796 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1848322089 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1848324903 |
CYP2R1
|
Health Risk |
Pathogenic |
— |
| RS1848344878 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1848346228 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, KCNQ1-related disorder |
| RS1848360153 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1848360692 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1848361555 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS1848365236 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jervell and Lange-Nielsen syndrome 1, Short QT syndrome type 2 |
| RS184841813 |
CACNA1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 23, Dystonia 23 |
| RS1848451807 |
FAR1
|
Health Risk |
Pathogenic |
— |
| RS184847335 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Connective tissue disorder |
| RS1848478518 |
PIK3C2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculocerebrodental syndrome, Oculocerebrodental syndrome |
| RS1848488567 |
FAS
|
Health Risk |
Likely pathogenic |
— |
| RS1848491059 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS184853466 |
RPGRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS1848538318 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome 1 |
| RS1848558128 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS1848574802 |
KCNQ1
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS1848577150 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1848596931 |
CYP2R1
|
Health Risk |
Pathogenic |
— |
| RS1848609806 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Long QT syndrome 1 |
| RS1848612978 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1848613169 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Cardiovascular phenotype |
| RS1848613641 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1848626159 |
PAX2
|
Health Risk |
Pathogenic |
Renal coloboma syndrome, Renal coloboma syndrome |
| RS1848628661 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Cardiac arrhythmia |
| RS1848629484 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1848631108 |
KCNQ1
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS1848631690 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1848632145 |
KCNQ1
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Cardiovascular phenotype |
| RS184863287 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1848633109 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Cardiac arrhythmia, Long QT syndrome |
| RS184863735 |
GPSM2
|
Health Risk |
Conflicting classifications of pathogenicity |
GPSM2-related disorder, GPSM2-related disorder |
| RS184864675 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS184866544 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Autosomal dominant nonsyndromic hearing loss 11 |
| RS1848668661 |
FAS
|
Health Risk |
Likely pathogenic |
— |
| RS1848671126 |
FAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS1848674892 |
FAS
|
Health Risk |
Pathogenic |
— |
| RS1848675068 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS184868637 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS184868814 |
HAVCR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Subcutaneous panniculitis-like T-cell lymphoma, HAVCR2-related disorder |
| RS184873330 |
ARL2
|
Health Risk |
Pathogenic |
Microcornea, rod-cone dystrophy |
| RS184878749 |
TUFM
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 4, Combined oxidative phosphorylation defect type 4 |
| RS184879368 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS184879571 |
XPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group C |
| RS1848801744 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS1848809864 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS184883937 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS1848840724 |
ODAD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia |
| RS184886917 |
EPS8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS184887106 |
VRK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 1A, Neuronopathy |
| RS1848879955 |
CYP2R1
|
Health Risk |
Pathogenic |
Vitamin D hydroxylation-deficient rickets, type 1B |
| RS184888200 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1848883206 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Monogenic short statue, IMAGe syndrome |
| RS1848884556 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1848914894 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848915004 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848926281 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848930692 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848931980 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848940003 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS184895368 |
RIPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 57, Inborn genetic diseases |
| RS1848953740 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848955612 |
CDKN1C
|
Health Risk |
Pathogenic |
— |
| RS1848955968 |
CDKN1C
|
Health Risk |
Pathogenic |
— |
| RS1848960369 |
CDKN1C
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848965153 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848966851 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848974871 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848977184 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848977725 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848978708 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1848979151 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1849030350 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS1849042311 |
ECHS1
|
Health Risk |
Pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |